Clinical Trial Update: An 8 Week Depression Study In Adults Diagnosed With Major Depressive Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for an 8-week study in adults with Major Depressive Disorder, sponsored by GlaxoSmithKline; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: GlaxoSmithKline | Conditions: Major Depressive Disorder (MDD) | Phase 2 | Status: COMPLETED